Now that SNSS has made the journey to 4 and back I am curious to see if there was a change in Blackrocks position. They bought a large stake just above 5 over a year ago. Have they added, sold or are they just holding content to wait for the trial results. This is an instituitional owners stock not a lot of retail owners to manipulate shares from or to leave holding the bag.
Agreed good thinking Pantsman. This is definitely an I-buyers stock with institutions ownership at 92.1% (source E*Trade) which by the way is down from 96% last summer. I suspect that investors are tiring of this stock and dilution surly will not help the situation. Still looking for an opportunity to buy back in. For now however most of my attention is on GALE where I have seen a 200% gain. F-Joe I see you have been following the GALE surge.
Is there a scheduled date for the Vosaroxin read out?